108997 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Psychrophilic enzymes compositions and methods for making and using same
#902High concentration alpha-glucosidase compositions for the treatment of Pompe disease
#903Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
#904Therapeutic nuclease compositions and methods
#905Phytic Acid as a Stabilizer for Phytase
#906Modulating the interaction between ZO-2/TJP2 and a Snail zinc finger transcription factor family member
#907HCV PROTEASE INHIBITORS AND USES THEREOF
#908Enzyme-pore constructs
#909Puro-DHFR quadrifunctional marker and its use in protein production
#910Immunogenic compositions and reagents for preparing
#911Methods and compositions for generating bioactive assemblies of increased complexity and uses
#912Domain Swapping Modules
#913Modified SAK gene for the production of recombinant proteins
#914Human arginase and site-directed pegylated human arginase and the use thereof
#915Functionalized graphene substrates
#916NPP1 fusion proteins
#917Enzymes for starch processing
#918SPARC binding ScFcs
#919Human arginase and pegylated human arginase and the use thereof
#920Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities
#921Erythrocyte-binding therapeutics
#922Histidyl-tRNA synthetase-Fc conjugates
#923SPARC binding ScFcs
#924SPARC binding ScFvs
#925Fusion proteins comprising type-II cohesin modules, multi-enzyme complexes comprising same and uses thereof
#926TARGETED IDURONATE-2-SULFATASE COMPOUNDS
#927Branched polymers
#928Process to prepare a stable thrombin composition
#929Method for increasing protein thermal stability
#930Treatment of cellulosic material and enzymes useful therein
#931Fragments of p97 and uses thereof
#932Coelenterazine analogues and coelenteramide analogues
#933METHODS AND COMPOSITIONS FOR IMPROVING SPERM FUNCTIONALITY
#934Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
#935REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT
#936Engineered E2 For Increasing The Content Of Free LYS11-Linked Ubiquitin
#937Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
#938Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
#939Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing
#940Method of treating HCV infection with a small molecule CHK2 inhibitor
#941Stabilisation of polypeptides
#942Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#943COMPOSITION AND METHOD FOR PRODUCING SAME
#944Covalent modification of biological macromolecules
#945ENZYME SUBSTRATE COMPRISING A FUNCTIONAL DYE AND ASSOCIATED TECHNOLOGY AND METHODS
#946Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
#947Regulation of specific spinal neurons regulating pain transmission via chimeric toxins
#948Thrombopoietic activity of tyrosyl-tRNA synthetase polypeptides
#949STABLE SOLUTIONS OF SACROSIDASE
#950Conjugated factor VIII molecules
#951Preparation of stabilized catalase enzymes using polyvinyl alcohol
#952CRISPR-Cas systems and methods for altering expression of gene products
#953Stabilizing agent for pharmaceutical proteins
#954Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
#955Compositions and Methods for cDNA Synthesis
#956Thermostable enzymes and methods of making and using the same
#957High concentration α-glucosidase compositions for the treatment of Pompe disease
#958Method for adapting a hydrolytic enzyme to a component that stabilizes the hydrolytic enzyme
#959FACTOR VIIA-POLYSIALIC ACID CONJUGATES HAVING PROLONGED IN VIVO HALF-LIFE
#960ENGINEERED CARBONIC ANHYDRASE PROTEINS FOR CO2 SCRUBBING APPLICATIONS
#961CRISPR-Cas systems and methods for altering expression of gene products
#962Sso7-polymerase conjugates with decreased non-specific activity
#963Factor IX: Remodeling and Glycoconjugation of Factor IX
#964Preparation of stabilized catalase enzymes with a surfactant
#965Stable lysis buffer mixture for extracting nucleic acids
#966Photocleavable linker
#967NPP1 FUSION PROTEINS
#968Thrombin solution and methods of use thereof
#969Therapeutic fusion proteins
#970Activated sialic acid derivatives for protein derivatisation and conjugation
#971Polymer factor IX moiety conjugates
#972Solubilized Phospholipids for Stabilizing Nucleic Acid Polymerases
#973Manufacturing method for silica encapsulated single-enzyme nanoparticles and single-enzyme nanoparticles manufactured by means of method
#974METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#975Methods of increasing the cellulolytic enhancing activity of a polypeptide
#976Enzymes for starch processing
#977Coelenterazine analogues and coelenteramide analogues
#978Fusion proteins for the treatment of allergic diseases
#979Solubilized phospholipids for stabilizing nucleic acid polymerases
#980RNase H-based assays utilizing modified RNA monomers
#981Chimeric alpha-amylase variants
#982Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide
#983Biotherapy for pain
#984Charged triplet-state quenchers for mitigation of photo-induced damage
#985Organic-inorganic nanoflowers, their synthesis and use
#986Pegylated analogue protein or canine urate oxidase, preparation method and use thereof
#987Scavenger receptor uptake for fabry disease enzyme replacement therapy
#988MICELLAR POLYSILOXANE ENZYME IMMOBILIZATION MATERIALS
#989Method for producing dry microbial cell powder
#990Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
#991Nucleic acid modifying enzymes
#992Conjugates of tumor necrosis factor inhibitors to functionalized polymers
#993Treatment with factor ix-albumin fusion protein
#994Dendrimer-based excipients for the attenuation of protein aggregation
#995Site specifically incorporated initiator for growth of polymers from proteins
#996IMMOBILIZED INTERFACIAL ENZYMES OF IMPROVED AND STABILIZED ACTIVITY
#997Treatment with factor VII-albumin fusion protein
#998Nano-encapsulated triggered-release viscosity breaker
#999Fusion protein for secretory protein expression
#1000PEG-modified arginine/lysine oxidoreductase
#1001COAGULATION FACTOR-TARGETING TO TLT-1 ON ACTIVATED PLATELETS
#1002Control of Cyanate in Aqueous Urea Solutions by Non-1,2-Ethylene Diamine Like Compounds for the Protection of Protein/Peptide Carbamylation
#1003HUMAN TISSUE KALLIKREIN 1 GLYCOSYLATION ISOFORMS
#1004MGMT-based method for obtaining high yields of recombinant protein expression
#1005Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
#1006Non-cytotoxic protein conjugates
#1007Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same
#1008Branched polymers
#1009Synthetic -derived chloroplast transit peptides
#1010Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same
#1011Long-acting coagulation factors and methods of producing same
#1012IL-1 BINDING PROTEINS
#1013Protective structure of substance to be protected, method of protecting substance to be protected, enzymatic reaction method, method of producing reaction product, method for adjusting the speed of enzymatic reaction, and enzyme material use kit
#1014Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
#1015Protein-based conjugates and self-assembled nanostructures
#1016Integrated sample preparation systems and stabilized enzyme mixtures
#1017Hydrogenase fusion protein for improved hydrogen production
#1018AMBIENT TEMPERATURE STABLE KITS FOR MOLECULAR DIAGNOSTICS
#1019NPP1 fusion proteins
#1020RET2IR CONJUGATES, RET2IR CONJUGATE SYSTEMS AND METHODS OF USE THEREOF
#1021Albumin Fusion Proteins
#1022METHOD FOR THE PURIFICATION AND STABILISATION OF ENZYME GLUCONATE DEHYDROGENASE (GADH, EC 1.1.99.3), ENZYME GLUCONATE DEHYDROGENASE (GADH, EC 1.1.99.3), AND THE USE OF ENZYME GLUCONATE DEHYDROGENASE (GADH, EC 1.1.99.3)
#1023Protein-enhanced surfactants for enzyme activation
#1024Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures
#1025CHIMERIC PROTEIN
#1026Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
#1027IMMUNOGENIC VACCINE
#1028Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities
#1029Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
#1030Ovr110 antibody compositions and methods of use
#1031Stabilized acid precursor and acid-enzyme formulations for drilling mud cake removal
#1032Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
#1033Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor
#1034Fusion molecule based on novel TAA variant
#1035RNA-Directed Packaging of Enzymes Within Protein Particles
#1036ENDOTHELIAL NITRIC OXIDE SYNTHASE
#1037Treatment of cellulosic material and enzymes useful therein
#1038METHODS AND PRODUCTS RELATING TO GSK3SS REGULATION
#1039Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
#1040Glyphosate resistant plants and associated methods
#1041Class of glyphosate resistance genes
#1042Compositions comprising a polypeptide having cellulolytic enhancing activity and a bicycle compound and uses thereof
#1043Chimeric Clotting Factors
#1044Glyphosate resistant plants and associated methods
#1045Dithioamine reducing agents
#1046CRYSTALS OF MEMBRANE PROTEINS
#1047Method for activating catalyst using photothermal nanomaterials
#1048Synthetic chloroplast transit peptides
#1049Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
#1050Chloroplast transit peptide
#1051Synthetic brassica-derived chloroplast transit peptides
#1052Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity
#1053Nucleic acid modifying enzymes
#1054Aldehyde tags, uses thereof in site-specific protein modification
#1055Processable single chain molecules and polypeptides made using same
#1056Factor IX polypeptides and methods of use thereof
#1057INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF HISTIDYL-TRNA SYNTHETASES
#1058Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
#1059Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#1060Non-leachable magnetic cross-linked enzyme aggregate
#1061NOVEL PROTEIN-POLYMER NANOCAPSULES
#1062Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
#1063Themostable Phytase Variants
#1064Chemically modified carbonic anhydrases useful in carbon capture systems
#1065Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Sulfur-Containing Compound And Uses Thereof
#1066ARTIFICIAL CELLULOSOME AND THE USE OF THE SAME FOR ENZYMATIC BREAKDOWN OF RESILIENT SUBSTRATES
#1067Conjugated Factor VIII Molecules
#1068Fusion proteins
#1069LONG-CHAIN OXYAMINOPOLYOL BASED GELATOR AND GEL
#1070THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
#1071Compositions comprising a polypeptide having cellulolytic enhancing activity and a nitrogen-containing compound and uses thereof
#1072Method and compositions for the detection of protein glycosylation
#1073P97-antibody conjugates and methods of use
#1074THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS
#1075STABILIZED FACTOR VIII VARIANTS
#1076Methods and compositions for regulation of transgene expression
#1077Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
#1078Methods and compositions for regulation of transgene expression
#1079NOVEL CBH1-EG1 FUSION PROTEINS AND USE THEREOF
#1080ENZYME CO-FACTOR ENHANCEMENT OF BIOSENSOR PERFORMANCE
#1081Puro-DHFR quadrifunctional marker and its use in protein production
#1082BLOOD MARKER FOR RENAL CANCER
#1083Factor IX polypeptides and methods of use thereof
#1084Immunoglobulin chimeric monomer-dimer hybrids
#1085Polypeptides having nucleic acid binding activity
#1086Methods and compositions for generating bioactive assemblies of increased complexity and uses
#1087PROCESS FOR THE PRODUCTION OF A REVERSIBLY INACTIVE ACIDIFIED PLASMIN COMPOSITION
#1088Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof
#1089Anti-diabetic compounds
#1090READTHROUGH ACETYLCHOLINESTERASE (ACHE-R) FOR TREATING OR PREVENTING PARKINSON'S DISEASE
#1091Reversibly inactivated acidified plasmin composition
#1092Stabilized protease composition
#1093Compositions comprising a polypeptide having cellulolytic enhancing activity and a dioxy compound and uses thereof
#1094Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof
#1095PEGylated mutated clostridium botulinum toxin
#1096Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
#1097Anti-TAT226 antibodies and immunoconjugates
#1098STABLE COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION AND SEQUENCING
#1099Humanized TTC and methods of use thereof
#1100STABILIZED LIQUID TENSIDE PREPARATION COMPRISING ENZYMES
#1101Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
#1102Method of providing a chemical or biological material in quantised form and system therefor
#1103GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA
#1104Methods and compositions for modification of the HPRT locus
#1105Constructs and methods for the assembly of biological pathways
#1106Conjugated blood coagulation factor VIIa
#1107Methods and compositions for modification of the locus
#1108Induction and stabilization of enzymatic activity in microorganisms
#1109Modified SAK gene for the production of recombinant proteins
#1110Fusion protein comprising C-terminal domain of RET protein and use thereof as a diagnosing marker
#1111MEDIATOR AND COHESIN CONNECT GENE EXPRESSION AND CHROMATIN ARCHITECTURE
#1112Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock
#1113Compositions and Methods for Determining Celiac Disease
#1114Methods, compositions, and kits for the treatment of matrix mineralization disorders
#1115Albumin fusion proteins
#1116CITRULLINATION OF HUMAN PEPTIDYLARGININE DEIMINASE 4 (PAD-4) REGULATES ITS FUNCTION AND IMMUNOGENICITY
#1117METHOD FOR SELECTIVE CONJUGATION OF ANALYTES TO ENZYMES WITHOUT UNWANTED ENZYME-ENZYME CROSS-LINKING
#1118FACTOR VIIA COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT
#1119Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification
#1120Methods and Tools for Screening Agents Exhibiting an Activity on Receptors of the Tumor Necrosis Factor Receptor Superfamily
#1121Method for Preserving Polypeptides Using A Sugar and Polyethyleneimine
#1122Coatings containing polymer modified enzyme for stable self-cleaning of organic stains
#1123Engineered E2 for increasing the content of free LYS11-linked ubiquitin
#1124PEG-urate oxidase conjugates and use thereof
#1125Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors
#1126MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES
#1127Labeled enzyme compositions, methods and systems
#1128INDUCTION AND STABILIZATION OF ENZYMATIC ACTIVITY IN MICROORGANISMS
#1129Method for increasing thermal stability and retaining activity of a protein
#1130Nanozymes, methods of making nanozymes, and methods of using nanozymes
#1131Targeted drug phosphorylcholine polymer conjugates
#1132THERMOSTABLE SUCROSE PHOSPHORYLASE
#1133HCV protease inhibitors and uses thereof
#1134METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#1135Lignin-based enzyme stabilizer
#1136Methods and apparatus for single molecule sequencing using energy transfer detection
#1137Branched polymers
#1138POLYMERASE COMPOSITIONS AND METHODS
#1139Matrices and media for storage and stabilization of biomolecules
#1140Solubilized phospholipids for stabilizing nucleic acid polymerases
#1141Stabilization of enzymes with stable coenzymes
#1142SSO7-polymerase conjugates with decreased non-specific activity
#1143ALBUMIN FUSION PROTEINS
#1144MODULATION OF CELLULAR PROTEIN FUNCTION BY ARTIFICIAL SUMO LIGASES
#1145Stabilization of thermolysin in aqueous solution
#1146VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF
#1147Antithrombotic compounds
#1148Therapeutic nuclease compositions and methods
#1149Glycopegylation methods and proteins/peptides produced by the methods
#1150PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE
#1151Xylanase composition with increased stability
#1152Vault complexes for cytokine delivery
#1153Non-cytotoxic protein conjugates
#1154Erythrocyte-binding therapeutics
#1155Modifications of peptide compositions to increase stability and delivery efficiency
#1156CHEMICALLY MODIFIED FACTOR IX
#1157POWDERY LIPASE PREPARATION AND USE THEREOF
#1158STABILIZED ENZYME COMPOSITIONS
#1159Nanofibers and morphology shifting micelles
#1160PEG-Urate Oxidase Conjugates and Use Thereof
#1161Method for preparing hybrid cross-linked enzyme-silica aggregates
#1162Rehydratable matrices for dry storage of TAQ polymerase in a microfluidic device
#1163Stable compositions for nucleic acid amplification and sequencing
#1164Technology for the Preparation of Microparticles
#1165Targeting of glycoprotein therapeutics
#1166Albumin fusion proteins
#1167Albumin Fusion Proteins
#1168Reverse transcriptase mixtures with improved storage stability
#1169Enzyme substrate comprising a functional dye and associated technology and methods
#1170Stabilized protease-containing solutions for purifying RNA-free DNA
#1171Crystals of membrane proteins
#1172STABILIZED CHEMICAL DEHYDRATION OF BIOLOGICAL MATERIAL
#1173Anti-TAT226 antibodies and immunoconjugates
#1174Pegylated L-Asparaginase
#1175Formulation for stabilizing proteins, which is free of mammalian excipient
#1176Purified extended polymerase/template complex for sequencing
#1177Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same
#1178Dried and stabilized ready-to-use composition containing nucleic acid polymerization enzymes for molecular biology applications
#1179Non-cytotoxic protein conjugates
#1180SPARC binding peptides and uses thereof
#1181SPARC binding ScFvs
#1182Chemically modified carbonic anhydrases useful in carbon capture systems
#1183Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation
#1184BLENDS CONTAINING PROTEASES
#1185Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
#1186DELIVERY OF THERAPEUTIC AGENTS TO THE BONE
#1187Engineering of yeast for cellulosic ethanol production
#1188Stabilized Liquid Enzyme Composition
#1189Process for accelerated capture of carbon dioxide
#1190Systems and methods for altering rates of enzymatic processes
#1191PEGylated mutated toxin
#1192Stable biocatalysts of penicillin acylase as gel aggregates and the process of manufacture thereof
#1193Method for purifying urate oxidase tetramers and octamers
#1194Aldehyde tags, uses thereof in site-specific protein modification
#1195Integrated sample preparation systems and stabilized enzyme mixtures
#1196Albumin Fusion Proteins
#1197Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
#1198LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
#1199STABILIZATION OF ASPARAGINASE
#1200Multiple mutation variants of serine protease